Screening cuts risk of dying from colorectal cancer nearly in half

Credit University of South Australia

CANCER DIGEST – Sept 21, 2019 – Screening cuts the risk of dying from colorectal cancer by as much as 45 percent researchers say. A new Australian analysis of 12, 906 records found that 37 percent of the patients had pre-diagnostic colonoscopies and were more likely to live longer than those who were diagnosed with colorectal cancer after experiencing symptoms.

Nanotechnology treatment for prostate cancer shows promise

CANCER DIGEST – Sept. 15, 2019 – Thirteen of the first 15 prostate cancer patients treated in a pilot clinical trial with nanoparticle-based therapy showed no detectable signs of cancer a year after treatment, researchers say.

Combination therapy shows promise for liver cancer

Image of liver – BodyParts3D public domain

CANCER DIGEST – Sept. 7, 2019 – A combination therapy may improve survival of liver cancer patients, contrary to an earlier study, according to Taiwanese researchers.

The study involved 2112 people with liver cancer, with 426 treated with a combination of the targeted drug sorafenib (Nexavar®) and a radiological therapy called TACE, for trans arterial chemoembolization, and 1686 in the sorafenib alone group.